March is National Colorectal Cancer Awareness Month, which makes it an important time to highlight both the ongoing public health challenge of colorectal cancer and the technologies that are helping reshape early detection and treatment. Despite being one of the most preventable and treatable cancers when caught early, the Colorectal Cancer Alliance (CCA) reminds us […]
The global in vitro diagnostic market continues to expand in both size and strategic importance. According to the 18th edition of Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, the industry now represents a $113 billion global market, up from just under $100 billion only five years ago. That growth alone signals […]
It is an exciting and dynamic time to be involved in the cell and gene therapy industry. Kalorama Information estimates the global cell and gene therapy market at approximately $16 billion in 2025, spanning key therapeutic areas such as oncology, neurology, musculoskeletal, dermatology, cardiology, and others. Kalorama projects double‑digit global market growth through 2030. “Kalorama […]
This special blog post is reprinted with permission from the Eye on IVD newsletter and features an interview with Kalorama Senior Editor Daniel Granderson, offering insights into the IVD market outlook for 2026. Before we shift attention to J.P. Morgan Healthcare this year, let’s get a sense of where we are in in vitro diagnostics […]
Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain Arlington, VA — June 2025 — A new survey of 195 diagnostic imaging and clinical lab professionals reveals that tariff policy uncertainty is already changing how providers plan staffing, purchasing, and vendor relationships. The latest Beyond the Bench […]
Kalorama Information is proud to introduce our recent report, The World Market for Cancer Diagnostics, 2024-2029. This comprehensive analysis provides an authoritative overview of the global cancer in vitro diagnostics (IVD) market, highlighting key trends, market sizing, and growth opportunities. In this report, you’ll find an in-depth review of the cancer IVD market, enriched with expert […]
The lab diagnostics industry is evolving at an unprecedented pace, driven by shifting regulations, decentralized testing growth, and rapid advancements in molecular and point-of-care technologies. Companies relying on outdated anecdotal insights or outdated data risk falling behind in a competitive landscape where market shifts and customer demands evolve in real time. “Custom Competitive Intelligence (CI) […]
In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]
Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It’s more than just bringing a product to market—it’s about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to […]
Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a notable increase in the number of cell and gene therapies in clinical development over the past decade. In the United States alone there are over 1,000 cell and gene therapies in clinical development, and more […]
